Tractus Vascular recently announced the first-in-human use of its Tractus Crossing Support Catheter.
Drs. John Rundback and Kevin Herman at American Endovascular and Amputation Prevention in West Orange N.J. performed the first procedures using Tractus CSC to treat patients with challenging cases of critical limb ischemia such as chronic total occlusion.
“The Tractus catheter tracked like ice and performed exceptionally well; the cases were all extremely successful,” Rundback said in a news release.
The Eatontown, N.J.-based company designed the catheter for chronic total occlusion and other vascular diseases. Tractus CSC is FDA cleared and has 0.014 in., 0.018 in. and 0.035 in. guidewire compatibility and lengths of 90 cm, 135 cm, 155 cm and 170 cm. The catheter is constructed using Tractus Vascular’s Jigsaw technology laser cut stainless steel shaft consisting of a continuous helical cut pattern forming interlocking teeth, according to the company. The distal “gusset cuts” provide a continuous stainless steel tip that extends the catheter shaft.
